After the decision by the Joint Senate over the removal of prescription discounts, potential buyers are now distancing themselves from any deal with DocMorris. One bidder has already dropped out, and two others have also announced their intention to refrain from any deal. With the banning of discounts on prescription drugs, DocMorris and other mail order pharmacies are seeing the removal of a key USP from their business strategy, significantly affecting company value.
[ilink url=“http://www.apotheke-adhoc.de/nachrichten/markt/docmorris-interessenten-springen-ab“]Link zur Quelle (Apotheke ad hoc)[/ilink]